We are pleased to present the shortened, 2-page summary protocol for the STARSurg DISCOVER study.
Please feel free to contact STARSurg
w: www.starsurg.org
e: collaborate@starsurg.org
t: @STARSurgUK
We are pleased to present the long version of the STARSurg DISCOVER study.
Please feel free to contact STARSurg
w: www.starsurg.org
e: collaborate@starsurg.org
t: @STARSurgUK
The final protocol (v5.3). Notable changes include:
1) Confirmation of audit standard (Page 6).
2) Refinement of inclusion and exclusion criteria (Page 7)
3) Confirmation of audit status (Appendix C)
4) Refinement of required data fields (Page 19) including definitions (Pages 20-25)
Presentation slides from our first meeting, held on Tuesday 10th September 2013 at the Royal College of Surgeons.
Find us on
Twitter @STARSurgUK
Facebook.com/STARSurgUK
Email: STARSurgUK@gmail.com
An Overview on Evidence-Based Clinical Guidelines for the Staff of the NICU of King Saud Medical City Presented in Wednesday March 20th, 2013 in Riyadh, KSA by Dr. Yasser Sami Amer
Participants: Dr Nabil AlOthaidan, Dr Haider Sumaily, Dr Tarek Abo ElMaaty, Dr Mohamed Jaaffar, Dr Samer Askoul, Dr Kussai Awad, Dr Angelito Narito, Dr Faiza Gaber, Dr Eiman Darwish, Dr Sharifa Alassiri. Michael Randy, Shanon and Dr Yazid, Dr Omnia, Dr Alaa and Dr Titiana and the respectable staff of the NICU in KSMC.
Special Thanks to Miss Nawf El-Noumsy for organization
Clinical Practice Guidelines initiative by the Healthcare Quality Directorate of the Alexandria University Hospitals, Alexandria, Egypt. For further details please refer to http://onlinelibrary.wiley.com/doi/10.1111/jep.12479/full
STARSurg, Tripartite Colorectal Conference, July 2014STARSurg
Tripartite is an international colorectal meeting of surgeons from across Europe, Australasia and the Americas.
Here we presented the colorectal-specific findings of STARSurg's first national collaborative cohort study, assesing the safety profile of NSAIDs in colorectal resection.
This session was conducted as a part of the 6th Resident Professional Development Course titled "Evidence-Based Medicine" in 9th SEPT 2015 at College of Medicine, King Saud University
We are pleased to present the long version of the STARSurg DISCOVER study.
Please feel free to contact STARSurg
w: www.starsurg.org
e: collaborate@starsurg.org
t: @STARSurgUK
The final protocol (v5.3). Notable changes include:
1) Confirmation of audit standard (Page 6).
2) Refinement of inclusion and exclusion criteria (Page 7)
3) Confirmation of audit status (Appendix C)
4) Refinement of required data fields (Page 19) including definitions (Pages 20-25)
Presentation slides from our first meeting, held on Tuesday 10th September 2013 at the Royal College of Surgeons.
Find us on
Twitter @STARSurgUK
Facebook.com/STARSurgUK
Email: STARSurgUK@gmail.com
An Overview on Evidence-Based Clinical Guidelines for the Staff of the NICU of King Saud Medical City Presented in Wednesday March 20th, 2013 in Riyadh, KSA by Dr. Yasser Sami Amer
Participants: Dr Nabil AlOthaidan, Dr Haider Sumaily, Dr Tarek Abo ElMaaty, Dr Mohamed Jaaffar, Dr Samer Askoul, Dr Kussai Awad, Dr Angelito Narito, Dr Faiza Gaber, Dr Eiman Darwish, Dr Sharifa Alassiri. Michael Randy, Shanon and Dr Yazid, Dr Omnia, Dr Alaa and Dr Titiana and the respectable staff of the NICU in KSMC.
Special Thanks to Miss Nawf El-Noumsy for organization
Clinical Practice Guidelines initiative by the Healthcare Quality Directorate of the Alexandria University Hospitals, Alexandria, Egypt. For further details please refer to http://onlinelibrary.wiley.com/doi/10.1111/jep.12479/full
STARSurg, Tripartite Colorectal Conference, July 2014STARSurg
Tripartite is an international colorectal meeting of surgeons from across Europe, Australasia and the Americas.
Here we presented the colorectal-specific findings of STARSurg's first national collaborative cohort study, assesing the safety profile of NSAIDs in colorectal resection.
This session was conducted as a part of the 6th Resident Professional Development Course titled "Evidence-Based Medicine" in 9th SEPT 2015 at College of Medicine, King Saud University
Alexandria Pediatric Center - Scientific Meeting Series 2017 - Meeting No. (7) conducted by Dr. Yasser Sami Amer
on 22nd August 2017 in Alexandria, Egypt
Presentation from the UK NSC conference in December 2016 about the recommendation on the use of pulse oximetry screening for critical congenital heart disease in newborns.
Overview of Evidence-Based Practice Guidelines Initiatives in the Hospitals of Two Universities in the Middle East and North Africa Countries: Alexandria University Faculty of Medicine and University Hospitals and King Saud University College of Medicine and Medical City
A parallel workshop to the first international Evidence-based medicine conference and workshop Adopting Clinical Guidelines where I participated as a guest speaker.
https://www.ssrsa.org/
STARSurg - student audit and research collaboration presentationDr Edward Fitzgerald
The Student Audit and Research in Surgery Collaborative (STARSurg) is the UK’s first national student-led research collaborative. STARSurg empowers students from all 33 medical schools in the UK to participate in high quality national audit and research studies in surgery which aim to improve patient care.
STARSurg fosters academic and research training, promotes evidence-based practice and builds a culture of collaboration necessary for 21st century medicine.
STARSurg continues to grow nationally and has since delivered three multi-centre and student-led national studies, which to date have included thousands of collaborators and over ten thousand patients across the UK and Ireland.
An introduction on Evidence-Based Clinical Practice Guidelines in Health Care Organizations
Brief on Alexandria Center for EBCPGs in Alexandria University Hospitals, Egypt
By Dr. Yasser Sami Abdel Dayem Amer, MBBCh, MS 2013
Special Thanks to
Prof Dr Mahmoud Elzalabany
Prof Dr Tarek Omar
Prof Dr Nabil Dowidar
Prof Dr Afaf Gaber
Part 1. An overview on implementation of CPGs
Part 2. CPGs & HTAs
Presented during the 2nd Regional Workshop for CPG Adaptation, Tunis, Tunisia May 24-26 2016
A collaborative between INA Sante, WHO-EMRO, KSU
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
A risk indicator can be any metric used to identify your risk exposure over time. It becomes a KRI when it tracks an important risk, or does so especially well because of its predictive value.
Dr Andrianov, CEO Cyntegrity, discusses the importance of keeping KRIs simple, the link to specific risks, and the emerging common industry KRIs.
A full recording of this webinar is available to MCC members: https://metricschampion.org/
Alexandria Pediatric Center - Scientific Meeting Series 2017 - Meeting No. (7) conducted by Dr. Yasser Sami Amer
on 22nd August 2017 in Alexandria, Egypt
Presentation from the UK NSC conference in December 2016 about the recommendation on the use of pulse oximetry screening for critical congenital heart disease in newborns.
Overview of Evidence-Based Practice Guidelines Initiatives in the Hospitals of Two Universities in the Middle East and North Africa Countries: Alexandria University Faculty of Medicine and University Hospitals and King Saud University College of Medicine and Medical City
A parallel workshop to the first international Evidence-based medicine conference and workshop Adopting Clinical Guidelines where I participated as a guest speaker.
https://www.ssrsa.org/
STARSurg - student audit and research collaboration presentationDr Edward Fitzgerald
The Student Audit and Research in Surgery Collaborative (STARSurg) is the UK’s first national student-led research collaborative. STARSurg empowers students from all 33 medical schools in the UK to participate in high quality national audit and research studies in surgery which aim to improve patient care.
STARSurg fosters academic and research training, promotes evidence-based practice and builds a culture of collaboration necessary for 21st century medicine.
STARSurg continues to grow nationally and has since delivered three multi-centre and student-led national studies, which to date have included thousands of collaborators and over ten thousand patients across the UK and Ireland.
An introduction on Evidence-Based Clinical Practice Guidelines in Health Care Organizations
Brief on Alexandria Center for EBCPGs in Alexandria University Hospitals, Egypt
By Dr. Yasser Sami Abdel Dayem Amer, MBBCh, MS 2013
Special Thanks to
Prof Dr Mahmoud Elzalabany
Prof Dr Tarek Omar
Prof Dr Nabil Dowidar
Prof Dr Afaf Gaber
Part 1. An overview on implementation of CPGs
Part 2. CPGs & HTAs
Presented during the 2nd Regional Workshop for CPG Adaptation, Tunis, Tunisia May 24-26 2016
A collaborative between INA Sante, WHO-EMRO, KSU
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
A risk indicator can be any metric used to identify your risk exposure over time. It becomes a KRI when it tracks an important risk, or does so especially well because of its predictive value.
Dr Andrianov, CEO Cyntegrity, discusses the importance of keeping KRIs simple, the link to specific risks, and the emerging common industry KRIs.
A full recording of this webinar is available to MCC members: https://metricschampion.org/
The summary protocol of the GlobalSurg II study.
GlobalSurg II aims to determine worldwide surgical site infection (SSI) rates following gastrointestinal surgery. The primary end point for the study is 30 day surgical site infection rate.
1. Any hospital in the world performing emergency or elective gastrointestinal surgery is eligible to enter
2. This is a low burden project; Only 30 data points per patient are required
3. Data collection: 4th January 2016 to 31st July 2016 (with follow-up of the last period until 30th August)
4. PubMed citable authorship attributed to all collaborators
For full details please visit: www.globalsurg.org
7DS Board Assurance Framework: Planning or June 2019 submissionNHS England
This webinar will provide:
• Key lessons learned from review of 7DS Board Assurance Framework (BAF) return in February
• Information on how to prepare for the next submission by 28th June 2019
• An opportunity to raise questions
STARSurg: The first student-led collaborativeSTARSurg
STARSurg is the first student-led collaborative to form. This UK based network of medical students, only a year old has managed to deliver a multi-centre national project, and is inviting medical students from the UK and Ireland to take part!
To find out more, please read these slides and visit www.starsurg.org
You can also email us at collaborate@starsurg.org
STARSurg Collaborators' Meeting September 2014 Abbreviated ProgrammeSTARSurg
Abbreviated Programme Book for STARSurg Collaborators' Meeting September 2014 at the Royal College of Surgeons of England, London, 16th September 2014.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
1. Student Audit and Research in Surgery
Supported by:
DISCOVER: Defining Surgical Complications in the Overweight
A multi-centre, student-led study of guidelines on obesity and post-operative complications.
STARSurg: Student Audit and Research in Surgery (STARSurg) is a national student-led
collaborative facilitating multi-centre audit and service evaluation
projects. STARSurg is co-ordinated by a steering group of medical
students and surgical trainees. It is represented locally by a network of 45
student leads covering all medical schools in the UK and the Republic of
Ireland.
Study participants: Any UK or Irish hospital offering elective and/or emergency surgery may
register DISCOVER. Mini-teams (two students and one doctor) will collect
data under the overall supervision of a consultant surgeon.
Study period: Each mini-team will collect data over a 14-day, consecutive period. Up to
three mini-teams may participate at each site collecting data over
successive periods. It is recommended that data collection takes place
during one of the following set periods:
§ Period 1: 0800 Wed 1st Oct to 0759 Wed 15th Oct.
§ Period 2: 0800 Wed 15th Oct to 0759 Wed 29th Oct.
§ Period 3: 0800 Wed 29th Oct to 0759 Wed 12th Nov.
Study registration: DISCOVER may be registered as clinical audit and/or service evaluation.
Study aims: (i) To establish compliance with NICE guidelines requiring early
identification of obese patients.
(ii) To determine the role of obesity as a risk factor for major post-operative
complications in current UK and Irish practice.
Audit gold standard: All patients should have BMI calculated on admission to hospital.
NICE CG 32, 1.2.2 All hospital inpatients on admission should be
screened for malnutrition.
NICE CG 32, 1.2.6 Screening should assess body mass index (BMI).
Inclusion criteria: All consecutive adult (age ≥18 years) patients with an overnight stay in
hospital, undergoing gastrointestinal surgery or hepatobiliary surgery
should be included. Include both emergency and elective patients and
both open and laparoscopic surgery.
Exclusion criteria: Minor anorectal surgery, transplant surgery, urological/ gynaecological/
vascular/ trauma indications for surgery.
Risk adjustment: Without adjusting for pre-operative risk, it is likely that any findings would
be biased. The following indices will be used to risk adjust outcomes:
§ ASA score.
§ Revised Cardiac Risk Index.
§ Malnutrition Universal Screening Tool (MUST) score.
§ Index of Multiple Deprivation.
2. Student Audit and Research in Surgery
Supported by:
Primary outcome: 30-day major complication rate (Clavien-Dindo grade III-V complications)
in the obese versus patients with normal weight.
Secondary outcomes: Procedure-specific complications, unplanned admission to critical care
unit, re-operation and re-admission.
Follow-up: The primary and secondary outcome measures will be recorded if they
occurred at any point from post-operative Day 1 (day of surgery) to Day
30. To ensure follow-up captures complications diagnosed at other
hospitals and in the community, mini-teams should consider calling
patients or general practitioners at 30-days. Telephone scripts will be
provided.
Data collection: Data will be collected and stored online through a secure, approved
University of Edinburgh server running the Research Electronic Data
Capture (REDCap) web application. REDCap is widely used
internationally by academic organisations to store research databases.
Data analysis: Data shall be analysed by the steering group. Data will not be analysed at
a surgeon level or centre level.
Authorship: All mini-team collaborators will be eligible for PubMed-citable authorship.
Each mini-team collaborator should participate in registering the audit,
identifying patients, collecting data and completing follow-up.
Funding: STARSurg is supported by INSPIRE.
INSPIRE is coordinated by the Academy of Medical Sciences and
supported by the Wellcome Trust. INSPIRE activities are designed and
delivered locally by individual medical schools.
Further information: For matters relating to mini-team setup and audit registration, please
contact your local lead (details at www.starsurg.org). For general enquiries
concerning the protocol, please contact the steering committee by email
(starsurguk@gmail.com) or on Twitter (@STARSurgUK).
Project timeline:
Sept 16 § National STARSurg meeting at RCSEng, London.
§ Full protocol published.
Aug 18 – Sept 26 § Local leads co-ordinate formation of mini-teams.
§ Audit is registered at each participating centre.
Oct 1 – Nov 12 Data collection periods (30-day follow-up ends Dec 12).
Dec 5 Preliminary results presented at National Research Collaborative Meeting
in Cardiff.